Cargando…
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis
PURPOSE: While glucocorticoids (GCs) are effective in large vessel vasculitis (LVV), they may cause serious adverse events (AEs), especially if taken for longer durations and at higher doses. Unfortunately, patients suffering from LVV often need long-term treatment with GCs; therefore, toxicity need...
Autores principales: | Palmowski, Andriko, Buttgereit, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550368/ https://www.ncbi.nlm.nih.gov/pubmed/33047263 http://dx.doi.org/10.1007/s11926-020-00961-0 |
Ejemplares similares
-
Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides
por: Schäfer, Valentin Sebastian, et al.
Publicado: (2020) -
Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases
por: Seitz, Luca, et al.
Publicado: (2022) -
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases
por: Lötscher, Fabian, et al.
Publicado: (2022) -
Patient Reported Outcomes in Large Vessel Vasculitides
por: Robson, Joanna, et al.
Publicado: (2021) -
Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides
por: Tombetti, Enrico, et al.
Publicado: (2021)